SynAct Pharma names Thomas Boesen as Chief Operating Officer
SynAct Pharma names Thomas Boesen as Chief Operating Officer SynAct Pharma AB (“SynAct”) today announced the appointment of Dr. Thomas Boesen as Chief Operating Officer (COO), effective immediately. His operational role as the new COO will be to drive forward the company’s three trials in clinical development with lead compound AP1189. Uppdaterad 2021-01-26 Publicerad 2021-01-26 Dr. Boesen has more than 20 years’ experience in the biotech and pharma industry. With a PhD in bioorganic chemistry from Copenhagen University, studies at...
Source: realtid.se